1
|
Vučinić N, Stankov K, Đan M, Barjaktarović I, Stokić E, Strajnić LJ, Obreht D, Đan I. Possible synergistic effect of apoE and LRP1 genotypes on metabolic syndrome development in Serbian patients. Mol Biol Rep 2019; 46:6345-6351. [PMID: 31538302 DOI: 10.1007/s11033-019-05076-z] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/18/2019] [Accepted: 09/13/2019] [Indexed: 11/25/2022]
Abstract
The modern way of life contributes to the higher frequency of a complex state medically called metabolic syndrome (MetS), which is an inevitable consequence of several most common diseases of modern civilization. Patients with MetS have three times higher risk of experiencing a heart attack or a stroke and twice higher possibility to die from them. Serbia holds the infamous third place in Europe in mortality from heart disease, just behind Russia and Ukraine. The study explores the correlation of every combination of genotypes of apoE (apolipoprotein E) and LRP1 (low density receptor- related protein 1) genes with presence of MetS, and the connection with each anthropometric and biochemical parameter in both tested groups. Study demonstrates the impact of genotype combinations on the emergence and development of the MetS in Serbia. 63 patients and 30 controls were included in the study, aged from 19 to 65. Each person genotype was determined by the polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) profile. Odds ratio (OR) values showed that the presence of apoE e3e4/LRP1 CC genotype combination of genotypes in patients multiplies the chance (7.6 times) for the occurrence of the MetS in comparison to the presence of other genotype combinations. Determining the genetic basis of MetS is one of the necessary steps in the prevention of disease, saving the cost of treatment, and in the design of targeted therapies.
Collapse
Affiliation(s)
- N Vučinić
- Department of Pharmacy, Faculty of Medicine, University of Novi Sad, Hajduk Veljkova 3, 21000, Novi Sad, Serbia.
| | - K Stankov
- Department of Biochemistry, Faculty of Medicine, University of Novi Sad, Novi Sad, Serbia
- Healthcare Management, Clinical Center of Vojvodina, Novi Sad, Serbia
| | - M Đan
- Department of Biology and Ecology, Faculty of Sciences, University of Novi Sad, Novi Sad, Serbia
| | - I Barjaktarović
- Department of General Education Subjects, Faculty of Medicine, University of Novi Sad, Novi Sad, Serbia
- Center for Laboratory Medicine, Clinical Center of Vojvodina, Novi Sad, Serbia
| | - E Stokić
- Department of Internal Medicine, Faculty of Medicine, University of Novi Sad, Novi Sad, Serbia
- Department of Endocrinology, Diabetes and Metabolic Disorders, Clinical Center of Vojvodina, Novi Sad, Serbia
| | - L J Strajnić
- Department of Dentistry, Faculty of Medicine, University of Novi Sad, Novi Sad, Serbia
- Dentistry Clinic of Vojvodina, Novi Sad, Serbia
| | - D Obreht
- Department of Forest and Conservation Sciences, University of British Columbia, 2424 Main Mall, Vancouver, BC, Canada
| | - I Đan
- Department of Oncology, Faculty of Medicine, University of Novi Sad, Novi Sad, Serbia
- Department of Radiotherapy, Institute of Oncology, Sremska Kamenica, Serbia
| |
Collapse
|